Best practice in the conduct of key nonclinical cardiovascular assessments in drug development: Current recommendations from the Safety Pharmacology Society
| Autor: | Leishman, D.J. a, ⁎, Beck, T.W. b, Dybdal, N. c, Gallacher, D.J. d, Guth, B.D. e, Holbrook, M. f, Roche, B. g, Wallis, R.M. f |
|---|---|
| Zdroj: | In Journal of Pharmacological and Toxicological Methods May-June 2012 65(3):93-101 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect